| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.006 |